Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 1
1(33.3%)
N/A
1(33.3%)
Phase 3
1(33.3%)
3Total
Phase 1(1)
N/A(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07784647Completed

A Combination Triple Pill Implementation Strategy for Blood Pressure cONtrol

Role: collaborator

NCT07569640Phase 3Recruiting

HFrEF Polypill in Sri Lanka RCT

Role: collaborator

NCT05452447Not ApplicableCompleted

Spatial Repellents for Aedes-borne Virus Control in Sri Lanka

Role: collaborator

NCT06831864Phase 1Completed

Heart Failure With Reduced Ejection Fraction Polypill Implementation Strategy in Sri Lanka

Role: collaborator

All 4 trials loaded